{"id":3073,"date":"2026-07-04T10:07:53","date_gmt":"2026-07-04T03:07:53","guid":{"rendered":"https:\/\/moderncancerhospital.net\/?page_id=3073"},"modified":"2026-07-27T05:08:09","modified_gmt":"2026-07-26T22:08:09","slug":"lung-cancer-mchg","status":"publish","type":"page","link":"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/","title":{"rendered":"Kanker Paru-paru"},"content":{"rendered":"<h1>Lung Cancer<\/h1>\n<h2>Overview and Epidemiology<\/h2>\n<p>Pulmonary malignancy represents one of the most prevalent forms of cancer worldwide, originating in the lung tissue and airways, including the trachea and main bronchi. This disease has the potential to disseminate to regional lymph nodes or spread to distant anatomical sites. Within Malaysia specifically, pulmonary cancer holds a significant position in cancer epidemiology. Among Malaysian males, it ranks as the leading cause of cancer-related mortality, responsible for approximately 25% of all male cancer deaths\u2014equivalent to one in every four male cancer patients succumbing to this disease. Notably, while it represents the second most common cancer diagnosis overall in Malaysia with a prevalence rate of 15.8%, it demonstrates markedly different patterns of occurrence in women, where it accounts for the fifth most frequently diagnosed malignancy at 5.6% of cases, yet remains the second most common cause of cancer-related deaths among females, contributing to 15% of all cancer mortality in women.<\/p>\n<p>[url gambar: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-140904649.png]<\/p>\n<p>Advanced-stage pulmonary malignancies, including those in middle and late phases of disease progression, may benefit from contemporary minimally invasive treatment modalities. These sophisticated therapeutic approaches offer advantages over conventional interventions, including reduced tissue trauma, diminished systemic side effects, and the potential to help patients avoid extensive surgical procedures. Through such techniques, patients may successfully circumvent the physical challenges associated with traditional open surgery and the substantial complications linked to conventional radiotherapy and chemotherapy regimens. These innovative approaches aim to meaningfully extend survival duration while simultaneously enhancing overall quality of life for affected individuals.<\/p>\n<h2>Classification and Histological Types<\/h2>\n<p>[url gambar: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-140954726.png]<\/p>\n<p>The classification of pulmonary cancer relies on histopathological examination and microscopic characteristics of the malignant cells. Understanding the specific subtype is essential for determining appropriate treatment strategies and predicting clinical outcomes.<\/p>\n<h3>Non-Small Cell Lung Cancer (NSCLC)<\/h3>\n<p>This category encompasses the vast majority of pulmonary cancer cases, accounting for approximately 80\u201385% of all diagnosed instances. NSCLC comprises several distinct subtypes, each with unique biological characteristics and clinical implications:<\/p>\n<ul>\n<li><strong>Adenocarcinoma<\/strong> \u2013 This represents the most frequently occurring subtype overall. It originates from glandular epithelial cells within the lungs and commonly appears in the outer peripheral regions of the lung tissue. This particular subtype occurs more frequently in individuals with no history of tobacco use.<\/li>\n<li><strong>Squamous Cell Carcinoma<\/strong> \u2013 This subtype demonstrates a strong association with smoking history and typically develops within the central airways and major bronchi of the lungs.<\/li>\n<li><strong>Large Cell Carcinoma<\/strong> \u2013 Characterized by poorly differentiated cellular architecture, this aggressive variant exhibits features distinct from other lung cancer subtypes and tends to progress rapidly.<\/li>\n<\/ul>\n<h3>Small Cell Lung Cancer (SCLC)<\/h3>\n<p>This classification represents a smaller but more aggressive subset, comprising 15\u201320% of all pulmonary cancer diagnoses. Small cell lung cancer exhibits several distinctive characteristics:<\/p>\n<ul>\n<li>Characterized by rapid cellular proliferation and early dissemination to distant sites<\/li>\n<li>Shows a pronounced connection to tobacco smoking history<\/li>\n<li>Frequently presents with paraneoplastic phenomena\u2014systemic manifestations caused by tumor secretion of hormone-like substances<\/li>\n<\/ul>\n<h2>Disease Staging<\/h2>\n<p>[url gambar: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-141516350.png]<\/p>\n<p>The staging framework for pulmonary cancer serves to characterize the anatomical extent of disease progression and establishes the foundation for treatment planning. The internationally recognized TNM classification system (incorporating Tumor dimensions, lymph Node involvement, and Metastatic spread) provides the standardized approach for determining cancer stage:<\/p>\n<ul>\n<li><strong>Stage 0 (Carcinoma in situ)<\/strong> \u2013 Malignant cells remain confined to the epithelial lining of the airways, without invasion into deeper tissues<\/li>\n<li><strong>Stage I<\/strong> \u2013 Neoplastic disease is localized exclusively within the lung parenchyma without demonstrable spread to regional lymph nodes<\/li>\n<li><strong>Stage II<\/strong> \u2013 Cancer has extended to involve nearby lymph nodes within the thorax<\/li>\n<li><strong>Stage III<\/strong> \u2013 Disease has progressed to involve lymph nodes throughout the mediastinum or structures adjacent to the lung<\/li>\n<li><strong>Stage IV<\/strong> \u2013 Metastatic dissemination has occurred to organs distant from the primary site<\/li>\n<\/ul>\n<h2>Risk Factors and Causative Elements<\/h2>\n<p>[url gambar: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-14155672.png]<\/p>\n<p>Multiple modifiable and non-modifiable factors contribute to the development of pulmonary malignancy. Recognition of these risk elements facilitates the identification of at-risk populations and supports preventive strategies:<\/p>\n<ul>\n<li>Current or historical cigarette smoking\u2014the most significant modifiable risk factor<\/li>\n<li>Exposure to environmental tobacco smoke through proximity to smokers<\/li>\n<li>Chronic exposure to radioactive radon gas, particularly in basements and enclosed spaces<\/li>\n<li>Professional exposure to carcinogenic substances including asbestos fibers, crystalline silica, nickel compounds, and hexavalent chromium<\/li>\n<li>Prolonged inhalation of air pollutants, specifically fine particulate matter (PM2.5)<\/li>\n<li>Familial predisposition\u2014a personal or family history of pulmonary cancer<\/li>\n<li>Pre-existing chronic pulmonary conditions such as chronic obstructive pulmonary disease (COPD) or pulmonary fibrosis<\/li>\n<\/ul>\n<h2>Clinical Manifestations and Symptoms<\/h2>\n<p>[url gambar: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-141624660.png]<\/p>\n<p>The clinical presentation of pulmonary cancer varies significantly depending on disease stage. Early-phase disease frequently produces minimal or non-specific symptoms, which commonly delays diagnosis:<\/p>\n<h3>Early-Stage Presentations<\/h3>\n<p>Patients with early-stage disease often remain asymptomatic or experience vague, non-specific complaints that may be attributed to other conditions.<\/p>\n<h3>Commonly Observed Symptoms<\/h3>\n<ul>\n<li>Persistent cough lasting several weeks or months, potentially accompanied by changes in cough character<\/li>\n<li>Hemoptysis\u2014the expulsion of blood-tinged sputum during coughing episodes<\/li>\n<li>Dyspnea\u2014progressive shortness of breath or difficulty with exertion<\/li>\n<li>Anterior thoracic discomfort or chest pain, particularly with deep breathing or coughing<\/li>\n<li>Unintentional weight loss without dietary modification or increased physical activity<\/li>\n<li>Constitutional symptoms including persistent fatigue and general malaise<\/li>\n<li>Hoarseness of voice resulting from involvement of structures affecting vocal cord function<\/li>\n<\/ul>\n<h3>Advanced Disease Manifestations<\/h3>\n<p>As disease progresses to advanced stages, additional symptoms emerge related to metastatic involvement:<\/p>\n<ul>\n<li>Osseous pain from skeletal metastases<\/li>\n<li>Neurological symptoms including headache, seizure activity, or cognitive changes from brain involvement<\/li>\n<li>Swelling of facial structures and cervical region resulting from superior vena cava syndrome\u2014compression of the major venous return pathway<\/li>\n<\/ul>\n<h2>Diagnostic Evaluation<\/h2>\n<p>[url gambar: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-141649753.png]<\/p>\n<p>Establishing a definitive diagnosis requires integration of imaging findings with tissue-based confirmation. A comprehensive diagnostic approach incorporates several modalities:<\/p>\n<h3>Radiological Assessment<\/h3>\n<ul>\n<li>Chest radiography serves as the initial screening tool for identifying pulmonary abnormalities<\/li>\n<li>Contrast-enhanced computed tomography provides detailed anatomical visualization of thoracic structures and regional lymph nodes<\/li>\n<li>Positron emission tomography-computed tomography (PET-CT) enables metabolic staging and detection of metastatic disease<\/li>\n<li>Magnetic resonance imaging assists in identifying involvement of the central nervous system<\/li>\n<\/ul>\n<h3>Tissue Confirmation<\/h3>\n<p>Histological or cytological diagnosis remains essential for treatment planning:<\/p>\n<ul>\n<li>Bronchoscopic procedures with simultaneous tissue sampling<\/li>\n<li>CT-guided transthoracic needle biopsy for peripheral lesions<\/li>\n<li>Endobronchial ultrasound (EBUS) technique for mediastinal assessment<\/li>\n<li>Surgical biopsy when other approaches are non-diagnostic<\/li>\n<\/ul>\n<h3>Molecular and Genetic Testing<\/h3>\n<p>In patients with non-small cell lung cancer, molecular profiling significantly influences therapeutic selection:<\/p>\n<ul>\n<li>Epidermal growth factor receptor (EGFR) mutation analysis<\/li>\n<li>Anaplastic lymphoma kinase (ALK) rearrangement detection<\/li>\n<li>ROS1, BRAF, and KRAS mutation status<\/li>\n<li>Programmed death-ligand 1 (PD-L1) expression assessment for immunotherapy eligibility<\/li>\n<\/ul>\n<h2>Treatment Approaches<\/h2>\n<h3>Conventional Therapeutic Modalities<\/h3>\n<p>Traditional treatment methods remain important components of comprehensive cancer management:<\/p>\n<ul>\n<li><strong>Surgical Intervention<\/strong> \u2013 Surgical removal of malignant tissue combined with systematic removal of regional lymph nodes that may harbor micrometastatic disease<\/li>\n<li><strong>Radiotherapeutic Treatment<\/strong> \u2013 Ionizing radiation directed at tumor sites to achieve cell death and local disease control<\/li>\n<li><strong>Chemotherapy<\/strong> \u2013 Systemic administration of cytotoxic agents, frequently employed in a palliative capacity for unresectable or widely metastatic advanced-stage malignancies<\/li>\n<li><strong>Complementary Traditional Medicine<\/strong> \u2013 Herbal and traditional therapeutic approaches may inhibit malignant progression, enhance immune function, and mitigate the toxic and adverse effects associated with conventional radiotherapy and chemotherapy regimens<\/li>\n<\/ul>\n<h3>Advanced Minimally Invasive Technologies<\/h3>\n<p>Contemporary tumor treatment technologies offer patients sophisticated options with reduced invasiveness and improved quality of life:<\/p>\n<ul>\n<li><strong>Interventional Therapy<\/strong> \u2013 Image-guided minimally invasive procedures utilizing small punctures (1-2 millimeters) for targeted tumor treatment across multiple malignancy types including pulmonary, hepatic, mammary, colorectal, and other solid tumors<\/li>\n<li><strong>Cryotherapeutic Ablation<\/strong> \u2013 Controlled freezing of malignant tissue using extreme cold to induce tumor cell destruction, applicable to lung cancer alongside various other solid neoplasms<\/li>\n<li><strong>Combined Knife Technology<\/strong> \u2013 Advanced cryogenic freezing system employing liquid-nitrogen ablation through strategically placed needles for precise tumor destruction<\/li>\n<li><strong>Nanoknife Technology<\/strong> \u2013 Cutting-edge ablation utilizing high-voltage electrical pulses to create nanometer-scale electroporated defects in tumor cell membranes, particularly valuable for tumors in sensitive anatomic locations<\/li>\n<li><strong>Particle Knife (Radioactive Seed Implantation)<\/strong> \u2013 Implantation of iodine-125 radioactive seeds that deliver sustained, localized radiation to destroy malignant cells over an extended timeframe<\/li>\n<li><strong>Radiofrequency Ablation<\/strong> \u2013 Image-guided thermal technique inducing controlled heat-mediated destruction of cancer cells through minimally invasive percutaneous puncture<\/li>\n<li><strong>Drug-Eluting Beads Transcatheter Arterial Chemoembolization (DEB-TACE)<\/strong> \u2013 Interventional approach using polymer beads loaded with anticancer medications to simultaneously occlude tumor blood supply and deliver concentrated chemotherapy<\/li>\n<\/ul>\n<h2>Frequently Asked Questions<\/h2>\n<h3>Is pulmonary cancer curable?<\/h3>\n<p>Early-phase pulmonary malignancy may achieve cure through surgical resection combined with supportive chemotherapy or radiation. Conversely, advanced-stage disease is typically managed through palliative approaches aimed at symptom control and survival prolongation.<\/p>\n<h3>Can individuals without smoking history develop lung cancer?<\/h3>\n<p>Absolutely. Environmental exposures, genetic predisposition, radon gas inhalation, occupational hazards, and air pollution represent well-documented causative factors in non-smokers.<\/p>\n<h3>What is the significance of molecular genetic testing?<\/h3>\n<p>Molecular analysis identifies specific mutations driving tumor growth, enabling personalized therapeutic approaches that target these genetic abnormalities, thereby substantially improving treatment efficacy and clinical results.<\/p>\n<h3>How effective is population screening for early detection?<\/h3>\n<p>Low-dose computed tomography screening demonstrates efficacy in reducing pulmonary cancer mortality within high-risk populations.<\/p>\n<h3>Why does delayed diagnosis frequently occur?<\/h3>\n<p>Early disease progression commonly remains asymptomatic or produces minimal clinical manifestations, resulting in disease advancement before diagnostic evaluation occurs.<\/p>\n<h3>Which populations should undergo screening programs?<\/h3>\n<p>High-risk individuals aged between 50 and 80 years with substantial cumulative smoking exposure benefit most from annual low-dose CT screening protocols.<\/p>\n<h2>Media Resources<\/h2>\n<p><strong>Images Referenced:<\/strong><\/p>\n<ul>\n<li>Lung Cancer Overview: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-140904649.png<\/li>\n<li>Cancer Types Classification: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-140954726.png<\/li>\n<li>Disease Staging: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-141516350.png<\/li>\n<li>Risk Factors: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-14155672.png<\/li>\n<li>Symptoms Overview: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-141624660.png<\/li>\n<li>Diagnostic Methods: https:\/\/img.asiancancer.com\/uploads\/allimg\/2026\/01\/13\/1-141649753.png<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Lung Cancer Overview and Epidemiology Pulmonary malignancy represents one of the most prevalent forms of cancer worldwide, originating in the lung tissue and airways, including the trachea and main bronchi. This disease has the potential to disseminate to regional lymph nodes or spread to distant anatomical sites. Within Malaysia specifically, pulmonary cancer holds a significant [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":31,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-3073","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lung Cancer - Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lung Cancer - Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care\" \/>\n<meta property=\"og:description\" content=\"Lung Cancer Overview and Epidemiology Pulmonary malignancy represents one of the most prevalent forms of cancer worldwide, originating in the lung tissue and airways, including the trachea and main bronchi. This disease has the potential to disseminate to regional lymph nodes or spread to distant anatomical sites. Within Malaysia specifically, pulmonary cancer holds a significant [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/\" \/>\n<meta property=\"og:site_name\" content=\"Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-26T22:08:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/cancer-types\\\/lung-cancer-mchg\\\/\",\"url\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/cancer-types\\\/lung-cancer-mchg\\\/\",\"name\":\"Lung Cancer - Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/#website\"},\"datePublished\":\"2026-07-04T03:07:53+00:00\",\"dateModified\":\"2026-07-26T22:08:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/cancer-types\\\/lung-cancer-mchg\\\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/cancer-types\\\/lung-cancer-mchg\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/cancer-types\\\/lung-cancer-mchg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/moderncancerhospital.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cancer Types\",\"item\":\"https:\\\/\\\/moderncancerhospital.net\\\/cancer-types\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Lung Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/#website\",\"url\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/\",\"name\":\"Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care\",\"description\":\"World-Class Precision Oncology, 40+ Years of Trusted Care\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/moderncancerhospital.net\\\/id\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lung Cancer - Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"id_ID","og_type":"article","og_title":"Lung Cancer - Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care","og_description":"Lung Cancer Overview and Epidemiology Pulmonary malignancy represents one of the most prevalent forms of cancer worldwide, originating in the lung tissue and airways, including the trachea and main bronchi. This disease has the potential to disseminate to regional lymph nodes or spread to distant anatomical sites. Within Malaysia specifically, pulmonary cancer holds a significant [&hellip;]","og_url":"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/","og_site_name":"Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care","article_modified_time":"2026-07-26T22:08:09+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimasi waktu membaca":"8 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/","url":"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/","name":"Lung Cancer - Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care","isPartOf":{"@id":"https:\/\/moderncancerhospital.net\/id\/#website"},"datePublished":"2026-07-04T03:07:53+00:00","dateModified":"2026-07-26T22:08:09+00:00","breadcrumb":{"@id":"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/moderncancerhospital.net\/id\/cancer-types\/lung-cancer-mchg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/moderncancerhospital.net\/"},{"@type":"ListItem","position":2,"name":"Cancer Types","item":"https:\/\/moderncancerhospital.net\/cancer-types\/"},{"@type":"ListItem","position":3,"name":"Lung Cancer"}]},{"@type":"WebSite","@id":"https:\/\/moderncancerhospital.net\/id\/#website","url":"https:\/\/moderncancerhospital.net\/id\/","name":"Modern Cancer Hospital Guangzhou \u2013 Precision Oncology Care","description":"World-Class Precision Oncology, 40+ Years of Trusted Care","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/moderncancerhospital.net\/id\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"}]}},"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"_links":{"self":[{"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/pages\/3073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/comments?post=3073"}],"version-history":[{"count":46,"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/pages\/3073\/revisions"}],"predecessor-version":[{"id":3696,"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/pages\/3073\/revisions\/3696"}],"up":[{"embeddable":true,"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/pages\/31"}],"wp:attachment":[{"href":"https:\/\/moderncancerhospital.net\/id\/wp-json\/wp\/v2\/media?parent=3073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}